Translating claims-based CHA2 DS2 -VaSc and HAS-BLED to ICD-10-CM: Impacts of mapping strategies.
Michael A Webster-ClarkTing-Ying HuangLaura HouSengwee TohPublished in: Pharmacoepidemiology and drug safety (2020)
Existing mapping strategies generally preserved the distributions of CHA2 DS2 -VaSc and HAS-BLED scores after ICD-10-CM transition. Both scores performed better in patients on no OACs or direct OACs than patients on warfarin.